Analytical validation of the tag-it high-throughput microsphere-based universal array genotyping platform: Application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms

被引:56
作者
Bortolin, S
Black, M
Modi, H
Boszko, I
Kobler, D
Fieldhouse, D
Lopes, E
Lacroix, JM
Grimwood, R
Wells, P
Janeczko, R
Zastawny, R
机构
[1] Tm Biosci Corp, Toronto, ON M5G 1Y8, Canada
[2] Univ Ottawa, Div Hematol, Dept Med, Ottawa Hlth Res Inst, Ottawa, ON, Canada
关键词
D O I
10.1373/clinchem.2004.035071
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: We have developed a novel, microsphere-based universal array platform referred to as the Tag-It(TM) platform. This platform is suitable for high-throughput clinical genotyping applications and was used for multiplex analysis of a panel of thrombophilia-associated single-nucleotide polymorphisms (SNPs). Methods: Genomic DNA from 132 patients was amplified by multiplex PCR using 6 primer sets, followed by multiplex allele-specific primer extension using 12 universally tagged genotyping primers. The products were then sorted on the Tag-It array and detected by use of the Luminex xMAP(TM) system. Genotypes were also determined by sequencing. Results: Empirical validation of the universal array showed that the highest nonspecific signal was 3.7% of the specific signal. Patient genotypes showed 100% concordance with direct DNA sequencing data for 736 SNP determinations. Conclusions: The Tag-It microsphere-based universal array platform is a highly accurate, multiplexed, high-throughput SNP-detection platform. (C) 2004 American Association for Clinical Chemistry.
引用
收藏
页码:2028 / 2036
页数:9
相关论文
共 31 条
  • [1] The thrombophilias: Well-defined risk factors with uncertain therapeutic implications
    Bauer, KA
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) : 367 - 373
  • [2] Venous thrombosis - The interaction of genes and environment
    Bertina, RM
    Rosendaal, FR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) : 1840 - 1841
  • [3] Bertina RM, 1997, CLIN CHEM, V43, P1678
  • [4] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BERTINA, RM
    KOELEMAN, BPC
    KOSTER, T
    ROSENDAAL, FR
    DIRVEN, RJ
    DERONDE, H
    VANDERVELDEN, PA
    REITSMA, PH
    [J]. NATURE, 1994, 369 (6475) : 64 - 67
  • [5] Dunbar SA, 2000, CLIN CHEM, V46, P1498
  • [6] Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR
    Erali, M
    Schmidt, B
    Lyon, E
    Wittwer, C
    [J]. CLINICAL CHEMISTRY, 2003, 49 (05) : 732 - 739
  • [7] The C536T transition in the tissue factor pathway inhibitor gene is not a common cause of venous thromboembolic disease in the UK population
    Evans, GD
    Langdown, J
    Brown, K
    Baglin, TP
    [J]. THROMBOSIS AND HAEMOSTASIS, 2000, 83 (03) : 511 - 511
  • [8] Evans JG, 2002, CLIN CHEM, V48, P1406
  • [9] A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease
    Franco, RF
    Morelli, V
    Lourenço, D
    Maffei, FH
    Tavella, MH
    Piccinato, CE
    Thomazini, IA
    Zago, MA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (02) : 556 - 559
  • [10] Franco RF, 1999, THROMB HAEMOSTASIS, V81, P676